2. 专升本
  3. Human cloning (克隆) technology could be used to reverse heart attacks. Scientists believe that they may be able to treat heart at

Human cloning (克隆) technology could be used to reverse heart attacks. Scientists believe that they may be able to treat heart at

admin2010-12-30  66
问题     Human cloning (克隆) technology could be used to reverse heart attacks. Scientists believe that they may be able to treat heart attack victims by cloning their healthy heart cells and injecting them into the areas of the heart that have been damaged, and other problems may be solved if human cloning and its technology are not forbidden.
    With cloning, infertile couples could have children. Current treatments for infertility, in terms of percentages (百分比) , are not very successful. Couples go through physically and emotionally painful procedures for a small chance of having children. Many couples run out of time and money without successfully having children. Human cloning could make it possible for many more infertile couples to have children than ever before. We should be able to clone the bone marrow (骨髓) for children and adults suffering from leukemia (白血病). It is expected to be one of the first benefits to come from cloning technology.
    We may learn how to switch cells on and off through cloning and thus be able to cure cancer. Cloning technology can be used to test for and perhaps cure gene-related diseases. The above are just a few examples of what human cloning technology can do for mankind.
    This new technology promises unprecedented advancement in medicine if people will release their fears and let the benefits begin.
The following are all examples of the benefits from the cloning technology EXCEPT
选项 A、treating heart attack victims
B、releasing people’s fears
C、treatment for infertility
D、curing cancer
答案B
解析 本题为事实细节题。由文章内容可知，A、C、D项都是克隆技术会带来的益处。releasing people’s fear是作者对人们提出的希望，希望人们能解除对克隆技术的恐惧，享受克隆技术带来的好处。故选B。
转载请注明原文地址:https://www.kaotiyun.com/show/H4LC777K
本试题收录于： 英语题库普高专升本分类
0

英语

普高专升本

相关试题推荐
随机试题
最新回复(0)